Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2023 ∙ Suteja, R. C. Salim, A. Suryanov, I. P. D. Tirtayasa, P. M. W. Duarsa, G. W. K.

Immunologic response and seroconversion following third-dose COVID-19 vaccination in solid organ transplant recipients: A meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Emmanouilidou-Fotoulaki, E. Karava, V. Dotis, J. Kondou, A. Printza, N.

Immunologic Response to SARS-CoV-2 Vaccination in Pediatric Kidney Transplant Recipients: A Systematic Review and Meta-Analysis

  • Children
  • Adolescents
  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Chaubey, I. Vijay, H. Govindaraj, S. Babu, H. Cheedarla, N. Shankar, E. M. Vignesh, R. Velu, V.

Impact of COVID-19 Vaccination on Pregnant Women

  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Adu, P. Poopola, T. Medvedev, O. N. Collings, S. Mbinta, J. Aspin, C. Simpson, C. R.

Implications for COVID-19 vaccine uptake: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Soltanzadi, A. Mirmosayyeb, O. Momeni Moghaddam, A. Ghoshouni, H. Ghajarzadeh, M.

Incidence of Bell's palsy after Coronavirus disease (COVID-19) vaccination: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Guo, B. Q. Li, H. B. Yang, L. Q.

Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12–17 years

  • Adolescents
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Moderate
2023 ∙ Santoli, G. Nurchis, M. C. Calabrò, G. E. Damiani, G.

Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence

  • All age groups
  • COVID-19
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Yenew, C. Dessie, A. M. Gebeyehu, A. A. Genet, A.

Intention to receive COVID-19 vaccine and its health belief model (HBM)-based predictors: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Tan, S. Y. Oka, P. Tan, N. C.

Intention to Vaccinate against COVID-19 in Adolescents: A Systematic Review

  • Adolescents
  • Adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Terrell, R. Alami, A. Krewski, D.

Interventions for COVID-19 Vaccine Hesitancy: A Systematic Review and Narrative Synthesis

  • Adolescents
  • Adults
  • Older adults
  • Healthcare workers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...